




Searching News Database: needle-free
HSMN NewsFeed - 7 Feb 2022
Vensica Closes $19 Million Round with Investment from Strategic Partner Merz
Vensica Closes $19 Million Round with Investment from Strategic Partner Merz
HSMN NewsFeed - 22 Dec 2020
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth
HSMN NewsFeed - 27 Feb 2017
Velano Vascular Receives Third FDA 510(k) Clearance for Innovative PIVO Needle-Free Blood Draw Technology
Velano Vascular Receives Third FDA 510(k) Clearance for Innovative PIVO Needle-Free Blood Draw Technology
HSMN NewsFeed - 1 Feb 2017
Glide Technologies Announces Successful £3.2 Million ($4.0 Million) Fundraising
Glide Technologies Announces Successful £3.2 Million ($4.0 Million) Fundraising
HSMN NewsFeed - 22 Dec 2016
AirXpanders Receives FDA de novo Clearance for AeroForm(R) Tissue Expander System
AirXpanders Receives FDA de novo Clearance for AeroForm(R) Tissue Expander System
HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 22 Jun 2016
AirXpanders' AeroForm(R) Tissue Expander Technology Showcased at Three International Surgery Conferences
AirXpanders' AeroForm(R) Tissue Expander Technology Showcased at Three International Surgery Conferences
HSMN NewsFeed - 23 Dec 2014
Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer
Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer
HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
HSMN NewsFeed - 19 Aug 2014
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
HSMN NewsFeed - 22 Jan 2014
Bioject's Distributor Meditrend International Receives Australian Device Registration
Bioject's Distributor Meditrend International Receives Australian Device Registration
HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
HSMN NewsFeed - 19 Nov 2013
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
HSMN NewsFeed - 5 Jun 2013
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System
HSMN NewsFeed - 19 Nov 2012
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
HSMN NewsFeed - 13 Nov 2012
Antares Pharma Announces Positive Results from Final MTX Medi-Jet(TM) Clinical Study
Antares Pharma Announces Positive Results from Final MTX Medi-Jet(TM) Clinical Study
HSMN NewsFeed - 8 Nov 2012
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
HSMN NewsFeed - 9 Aug 2012
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
HSMN NewsFeed - 26 Jun 2012
ICU Medical, Inc. Signs Agreement with ROi for MicroClave(R) Clear Needlefree IV Connector
ICU Medical, Inc. Signs Agreement with ROi for MicroClave(R) Clear Needlefree IV Connector
HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
HSMN NewsFeed - 4 Aug 2011
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
HSMN NewsFeed - 2 Mar 2011
AirXpanders Raises $8M Through Series C Financing and Working Capital Line
AirXpanders Raises $8M Through Series C Financing and Working Capital Line
HSMN NewsFeed - 11 Jan 2011
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
HSMN NewsFeed - 13 Jul 2010
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
HSMN NewsFeed - 25 Jan 2010
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
HSMN NewsFeed - 8 Jul 2009
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
HSMN NewsFeed - 6 Apr 2009
Bioject Announces FDA Market Clearance for the Zetajet Needle-Free Injection Therapy System
Bioject Announces FDA Market Clearance for the Zetajet Needle-Free Injection Therapy System
HSMN NewsFeed - 13 Oct 2008
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 10 Sep 2008
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
HSMN NewsFeed - 8 Sep 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
HSMN NewsFeed - 7 Jul 2008
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
HSMN NewsFeed - 30 Jun 2008
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
HSMN NewsFeed - 30 Jan 2008
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
HSMN NewsFeed - 1 Nov 2007
Valeritas Announces Brand Name V-Go(TM) for Disposable Insulin Delivery Device
Valeritas Announces Brand Name V-Go(TM) for Disposable Insulin Delivery Device
HSMN NewsFeed - 18 Oct 2007
B. Braun and Premier Sign for Safety: Companies Renew Agreement for Introcan Safety(R) IV Catheter
B. Braun and Premier Sign for Safety: Companies Renew Agreement for Introcan Safety(R) IV Catheter
HSMN NewsFeed - 12 Oct 2007
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
HSMN NewsFeed - 3 Oct 2007
Bioject Announces Roche and Trimeris Update on the Use of Fuzeon(R) with Biojector(R) 2000
Bioject Announces Roche and Trimeris Update on the Use of Fuzeon(R) with Biojector(R) 2000
HSMN NewsFeed - 3 Oct 2007
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
HSMN NewsFeed - 26 Sep 2007
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
HSMN NewsFeed - 9 Aug 2007
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
HSMN NewsFeed - 19 Jul 2007
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
HSMN NewsFeed - 7 Jun 2007
Zogenix Appoints David Nassif Executive Vice President and Chief Financial Officer
Zogenix Appoints David Nassif Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
HSMN NewsFeed - 30 Jan 2007
Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device
Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device
HSMN NewsFeed - 1 Nov 2006
Carrington's DelSite Subsidiary Presents Data on Needle-Free Vaccine Technology
Carrington's DelSite Subsidiary Presents Data on Needle-Free Vaccine Technology
HSMN NewsFeed - 16 Oct 2006
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
HSMN NewsFeed - 11 Oct 2006
Roche and Trimeris Provide Update on Development of Needle-Free Administration for FUZEON(R)
Roche and Trimeris Provide Update on Development of Needle-Free Administration for FUZEON(R)
HSMN NewsFeed - 4 Oct 2006
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
HSMN NewsFeed - 2 Oct 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
HSMN NewsFeed - 18 Jul 2006
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
HSMN NewsFeed - 23 May 2006
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
HSMN NewsFeed - 9 May 2006
Norwood Abbey Highlights Needle-Free Drug Delivery System and Commercial Strategic Update
Norwood Abbey Highlights Needle-Free Drug Delivery System and Commercial Strategic Update
HSMN NewsFeed - 9 May 2006
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
Additional items found! 114

Members Archive contains
114 additional stories matching:
needle-free
(Password required)
needle-free
(Password required)